Max Scherzer's Cortisone Shot Is the Blue Jays' Right Thumb Problem That Won't Go Away

Here's the thing about getting a cortisone injection to manage pain: it buys you time, but it doesn't fix what's actually broken. And that's exactly where Max Scherzer finds himself right now with the Toronto Blue Jays, getting a cortisone shot to help manage inflammation in his right thumb. This isn't a feel-good update. This is damage control.

When a Veteran Ace Needs to Manage Injury Instead of Dominate

Scherzer is getting that cortisone injection to help manage his right thumb, and if you've followed baseball long enough, you know what that means. A future Hall of Famer doesn't take this route unless something is seriously limiting his ability to pitch at his level. The Blue Jays are banking on this injection buying enough time to get through the season, but managing pain is not the same as being healthy.

For a rotation that's already dealing with plenty of other issues, losing Scherzer to anything more serious would be catastrophic. This is a veteran presence, a guy who's been there and knows how to win. But right now, he's fighting inflammation, not just opponents.

Toronto's Pitching Staff Is Under Siege

The timing here is rough. The Blue Jays just designated Eric Lauer for assignment after his struggles on the mound, and now they're scrambling to figure out who fills that void in the rotation. They're looking at internal candidates, considering guys like Spencer Miles to step up and handle the fifth starter job. Meanwhile, they recalled Yariel Rodríguez from Triple-A Buffalo, hoping he can contribute after losing his spot on the 40-man roster previously.

Rodríguez struck out two in his return to the big leagues, which is something. But when you're dealing with a veteran pitcher managing a chronic injury while trying to replace a starter you just DFA'd, the depth chart gets real thin real fast. And that's before you factor in that Bieber is still working his way back, throwing one-inning live BP as he progresses.

The Cortisone Clock Starts Now

The Blue Jays are betting on Scherzer's experience and competitiveness to push through this. Cortisone buys time, and in May, time is what matters most. But every game counts when you're trying to build something, and losing production from one of your most trusted arms isn't a luxury any contender can absorb for long.

The question now is whether that injection gets Scherzer through the stretch, or whether this becomes a bigger issue down the line. For a team already juggling roster moves and pitching depth, that's a conversation nobody wants to have.

This article was created with AI assistance and reviewed by Seattle On Tap editorial staff. Always verify information with official team sources.